World Health Organization Raises Alert Over Severe Scarcity of Weight-Loss Jabs
Under a tenth of people who could benefit from obesity jabs such as Wegovy can access them, caution the WHO as it issues its initial recommendations on the medications.
Considering more than one billion people worldwide currently living with obesity, it is urging more widespread and fairer availability to GLP-1 medication.
Per estimates, in excess of 2,000,000,000 could be obese by 2030 if no action is taken.
"Our new guidelines acknowledges that obesity is a lifelong illness that can be managed with thorough and continuous treatment," remarked the agency's head Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and supply-chain constraints are major hurdles to broad availability to the injections that can help people shift considerable body mass, says the organization.
GLP-1 Therapy Shortage
Even in the present most optimistic outlook, the production of these medications could only cover around 100 million people – under 10% of those who need them, as stated by the WHO.
The recommendation encourages countries and companies to expand availability, by strategies such as patent sharing.
Exclusive production rights on a key compound – the core ingredient of Novo Nordisk's Wegovy – is set to lapse in multiple nations in 2026.
The Way Obesity Injections Operate
These medications imitate a biological compound to reduce digestion speed, suppress the appetite and boost the sense of being full so individuals eat less.
Individuals commonly begin shedding pounds in the initial weeks of starting on the weekly injections.
Research suggests users may see weight return after a year of stopping the medication, because their typical appetite resume.
Being overweight or obese elevates your likelihood for contracting medical conditions, like type 2 diabetes, cardiovascular issues, brain attack, and some cancers.
Excess weight affects people in countries worldwide and was linked to millions of fatalities worldwide in 2024, as per the health agency.
